Skip to main content
SpringerLink
Log in

There is Evidence for the Superiority of Protons and Heavy Ions, Pro

  • Chapter
  • First Online:
Radiotherapy in Prostate Cancer

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

This chapter deals with the question of whether irradiation of the prostate with protons or other particles is superior to X-rays. The physical and biological principles of particle beam therapy are presented and the clinical aspects of proton and carbon ion therapy of the prostate are discussed. Relevant studies of particle therapies are introduced and discussed relating to differences in comparison to modern X-ray techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akakura K, Tsujii H, Morita S, Tsuji H, Yagishita T, Isaka S, Ito H, Akaza H, Hata M, Fujime M et al (2004) Phase I/II clinical trials of carbon ion therapy for prostate cancer. Prostate 58(3):252–258

    Article  CAS  PubMed  Google Scholar 

  • Allen AM, Pawlicki T, Dong L, Fourkal E, Buyyounouski M, Cengel K, Plastaras J, Bucci MK, Yock TI, Bonilla L et al (2012) An evidence based review of proton beam therapy: the report of ASTRO’s emerging technology committee. Radiother Oncol J Eur Soc Ther Radiol Oncol 103(1):8–11

    Article  Google Scholar 

  • Arcangeli G, Saracino B, Gomellini S, Petrongari MG, Arcangeli S, Sentinelli S, Marzi S, Landoni V, Fowler J, Strigari L (2010) A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys 78(1):11–18

    Article  PubMed  Google Scholar 

  • Athar BS, Bednarz B, Seco J, Hancox C, Paganetti H (2010) Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients. Phys Med Biol 55(10):2879–2891

    Article  PubMed Central  PubMed  Google Scholar 

  • Bauer J, Unholtz D, Kurz C, Parodi K (2013a) An experimental approach to improve the Monte Carlo modelling of offline PET/CT-imaging of positron emitters induced by scanned proton beams. Phys Med Biol 58(15):5193–5213

    Article  CAS  PubMed  Google Scholar 

  • Bauer J, Unholtz D, Sommerer F, Kurz C, Haberer T, Herfarth K, Welzel T, Combs SE, Debus J, Parodi K (2013b) Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment. Radiother Oncol J Eur Soc Ther Radiol Oncol 107(2):218–226

    Article  CAS  Google Scholar 

  • Bohlen TT, Brons S, Dosanjh M, Ferrari A, Fossati P, Haberer T, Patera V, Mairani A (2012) Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters. Phys Med Biol 57(23):7983–8004

    Article  CAS  PubMed  Google Scholar 

  • Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP (2002) Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52(1):6–13

    Article  PubMed  Google Scholar 

  • Cahlon O, Zelefsky MJ, Shippy A, Chan H, Fuks Z, Yamada Y, Hunt M, Greenstein S, Amols H (2008) Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 71(2):330–337

    Article  CAS  PubMed  Google Scholar 

  • Carabe A, Moteabbed M, Depauw N, Schuemann J, Paganetti H (2012) Range uncertainty in proton therapy due to variable biological effectiveness. Phys Med Biol 57(5):1159–1172

    Article  PubMed  Google Scholar 

  • Carabe A, Espana S, Grassberger C, Paganetti H (2013) Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver. Phys Med Biol 58(7):2103–2117

    Article  PubMed  Google Scholar 

  • Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ (2013) Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 87(1):46–52

    Article  CAS  PubMed  Google Scholar 

  • Creutz EC, Wilson RR (1946) Mono-energetic protons from a cyclotron. Rev Sci Instr 17(10):385–388

    Article  CAS  Google Scholar 

  • Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, Yarnold J, Horwich A (1999) Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353(9149):267–272

    Article  CAS  PubMed  Google Scholar 

  • Elsasser T, Kramer M, Scholz M (2008) Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. Int J Radiat Oncol Biol Phys 71(3):866–872

    Article  PubMed  Google Scholar 

  • Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122

    Article  CAS  PubMed  Google Scholar 

  • Enghardt W, Parodi K, Crespo P, Fiedler F, Pawelke J, Ponisch F (2004) Dose quantification from in-beam positron emission tomography. Radiother Oncol J Eur Soc Ther Radiol Oncol 73(Suppl 2):S96–S98

    Article  Google Scholar 

  • Fowler JF, Ritter MA, Chappell RJ, Brenner DJ (2003) What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56(4):1093–1104

    Article  PubMed  Google Scholar 

  • Frey K, Bauer J, Unholtz D, Kurz C, Kramer M, Bortfeld T, Parodi K (2014) TPSPET-A TPS-based approach for in vivo dose verification with PET in proton therapy. Phys Med Biol 59(1):1–21

    Article  CAS  PubMed  Google Scholar 

  • Gerweck LE, Kozin SV (1999) Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 50(2):135–142

    Article  CAS  Google Scholar 

  • Haberer T, Debus J, Eickhoff H, Jakel O, Schulz-Ertner D, Weber U (2004) The Heidelberg Ion Therapy Center. Radiother Oncol J Eur Soc Ther Radiol Oncol 73(Suppl 2):S186–S190

    Article  Google Scholar 

  • Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65(1):1–7

    Article  PubMed  Google Scholar 

  • Hsi WC, Indelicato DJ, Vargas C, Duvvuri S, Li Z, Palta J (2009) In vivo verification of proton beam path by using post-treatment PET/CT imaging. Med Phys 36(9):4136–4146

    Article  CAS  PubMed  Google Scholar 

  • Ishikawa H, Tsuji H, Kamada T, Yanagi T, Mizoe JE, Kanai T, Morita S, Wakatsuki M, Shimazaki J, Tsujii H (2006a) Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. Radiother Oncol J Eur Soc Ther Radiol Oncol 81(1):57–64

    Article  Google Scholar 

  • Ishikawa H, Tsuji H, Kamada T, Hirasawa N, Yanagi T, Mizoe JE, Akakura K, Suzuki H, Shimazaki J, Tsujii H (2006b) Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer. Int J Radiat Oncol Biol Phys 66(4):1084–1091

    Article  PubMed  Google Scholar 

  • Ishikawa H, Tsuji H, Kamada T, Hirasawa N, Yanagi T, Mizoe JE, Akakura K, Suzuki H, Shimazaki J, Nakano T et al (2008) Adverse effects of androgen deprivation therapy on persistent genitourinary complications after carbon ion radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 72(1):78–84

    Article  CAS  PubMed  Google Scholar 

  • Ishikawa H, Tsuji H, Kamada T, Akakura K, Suzuki H, Shimazaki J, Tsujii H (2012) Carbon-ion radiation therapy for prostate cancer. Int J Urol Off J Jpn Urol Assoc 19(4):296–305

    Google Scholar 

  • Jakel O, Reiss P (2007) The influence of metal artefacts on the range of ion beams. Phys Med Biol 52(3):635–644

    Article  PubMed  Google Scholar 

  • Jarosek S, Elliott S, Virnig BA (2011) Proton beam radiotherapy in the U.S. Medicare population: growth in use between 2006 and 2009: Data Points # 10. In: Data points publication series, Rockville (MD)

    Google Scholar 

  • Jones B (2009) Joint symposium 2009 on carbon ion radiotherapy. Br J Radiol 82(983):884–889

    Article  CAS  PubMed  Google Scholar 

  • Karger CP, Jakel O (2007) Current status and new developments in ion therapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al] 183(6):295–300

    Article  Google Scholar 

  • Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A (2008) Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70(1):67–74

    Article  PubMed  Google Scholar 

  • Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Mahadevan A (2007) Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland clinic experience. Int J Radiat Oncol Biol Phys 68(5):1424–1430

    Article  PubMed  Google Scholar 

  • Livsey JE, Cowan RA, Wylie JP, Swindell R, Read G, Khoo VS, Logue JP (2003) Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis. Int J Radiat Oncol Biol Phys 57(5):1254–1259

    Article  PubMed  Google Scholar 

  • Lodge M, Pijls-Johannesma M, Stirk L, Munro AJ, De Ruysscher D, Jefferson T (2007) A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol J Eur Soc Ther Radiol and Oncol 83(2):110–122

    Article  Google Scholar 

  • Macias V, Biete A (2009) Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials. In: Clinical & translational oncology : official publication of the federation of Spanish oncology societies and of the national cancer institute of Mexico, vol 11(7), pp 437-445

    Google Scholar 

  • Mackin D, Peterson S, Beddar S, Polf J (2012) Evaluation of a stochastic reconstruction algorithm for use in Compton camera imaging and beam range verification from secondary gamma emission during proton therapy. Phys Med Biol 57(11):3537–3553

    Article  PubMed Central  PubMed  Google Scholar 

  • Mayahara H, Murakami M, Kagawa K, Kawaguchi A, Oda Y, Miyawaki D, Sasaki R, Sugimura K, Hishikawa Y (2007) Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. Int J Radiat Oncol Biol Phys 69(2):434–443

    Article  PubMed  Google Scholar 

  • Nihei K, Ogino T, Ishikura S, Kawashima M, Nishimura H, Arahira S, Onozawa M (2005) Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan. Jpn J Clin Oncol 35(12):745–752

    Article  PubMed  Google Scholar 

  • Nikoghosyan AV, Schulz-Ertner D, Herfarth K, Didinger B, Munter MW, Jensen AD, Jakel O, Hoess A, Haberer T, Debus J (2011) Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer—acute toxicity of 12C for PC. Acta Oncol 50(6):784–790

    Article  PubMed  Google Scholar 

  • Nishio T, Miyatake A, Inoue K, Gomi-Miyagishi T, Kohno R, Kameoka S, Nakagawa K, Ogino T (2008) Experimental verification of proton beam monitoring in a human body by use of activity image of positron-emitting nuclei generated by nuclear fragmentation reaction. Radiol Phys Technol 1(1):44–54

    Article  PubMed  Google Scholar 

  • Olsen DR, Bruland OS, Frykholm G, Norderhaug IN (2007) Proton therapy—a systematic review of clinical effectiveness. Radiother Oncol J Eur Soc Ther Radiol Oncology 83(2):123–132

    Article  Google Scholar 

  • Paganetti H (2012) Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys Med Biol 57(11):R99–R117

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Paganetti H, Gerweck LE, Goitein M (2000) The general relation between tissue response to x-radiation (alpha/beta-values) and the relative biological effectiveness (RBE) of protons: prediction by the Katz track-structure model. Int J Radiat Biol 76(7):985–998

    Article  CAS  PubMed  Google Scholar 

  • Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, Suit HD (2002) Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 53(2):407–421

    Article  PubMed  Google Scholar 

  • Parodi K, Paganetti H, Shih HA, Michaud S, Loeffler JS, DeLaney TF, Liebsch NJ, Munzenrider JE, Fischman AJ, Knopf A et al (2007a) Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. Int J Radiat Oncol Biol Phys 68(3):920–934

    Article  PubMed Central  PubMed  Google Scholar 

  • Parodi K, Ferrari A, Sommerer F, Paganetti H (2007b) Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code. Phys Med Biol 52(12):3369–3387

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Peschke P, Karger CP, Scholz M, Debus J, Huber PE (2011) Relative biological effectiveness of carbon ions for local tumor control of a radioresistant prostate carcinoma in the rat. Int J Radiat Oncol Biol Phys 79(1):239–246

    Article  CAS  PubMed  Google Scholar 

  • Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I (2002) Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53(5):1097–1105

    Article  PubMed  Google Scholar 

  • Robertson JB, Williams JR, Schmidt RA, Little JB, Flynn DF, Suit HD (1975) Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells. Cancer 35(6):1664–1677

    Article  CAS  PubMed  Google Scholar 

  • Rossi CJ Jr, Slater JD, Yonemoto LT, Jabola BR, Bush DA, Levy RP, Grove R, Slater JM (2004) Influence of patient age on biochemical freedom from disease in patients undergoing conformal proton radiotherapy of organ-confined prostate cancer. Urology 64(4):729–732

    Article  PubMed  Google Scholar 

  • Scholz M, Jakob B, Taucher-Scholz G (2001) Direct evidence for the spatial correlation between individual particle traversals and localized CDKN1A (p21) response induced by high-LET radiation. Radiat Res 156(5 Pt 1):558–563

    Article  CAS  PubMed  Google Scholar 

  • Schulz-Ertner D, Jakel O, Schlegel W (2006) Radiation therapy with charged particles. Seminars in radiation oncology 16(4):249–259

    Article  PubMed  Google Scholar 

  • Shimazaki J, Akakura K, Suzuki H, Ichikawa T, Tsuji H, Ishikawa H, Harada M, Tsujii H (2006) Monotherapy with carbon ion radiation for localized prostate cancer. Jpn J Clin Oncol 36(5):290–294

    Article  PubMed  Google Scholar 

  • Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, Young RH, Shipley JW, Zietman AL, Biggs PJ et al (1995) Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32(1):3–12

    Article  CAS  PubMed  Google Scholar 

  • Slater JD, Rossi CJ Jr, Yonemoto LT, Bush DA, Jabola BR, Levy RP, Grove RI, Preston W, Slater JM (2004) Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 59(2):348–352

    Article  PubMed  Google Scholar 

  • Tsuji H, Yanagi T, Ishikawa H, Kamada T, Mizoe JE, Kanai T, Morita S, Tsujii H (2005) Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys 63(4):1153–1160

    Article  PubMed  Google Scholar 

  • Wakatsuki M, Tsuji H, Ishikawa H, Yanagi T, Kamada T, Nakano T, Suzuki H, Akakura K, Shimazaki J, Tsujii H (2008) Quality of life in men treated with carbon ion therapy for prostate cancer. Int J Radiat Oncol Biol Phys 72(4):1010–1015

    Article  PubMed  Google Scholar 

  • Wilson RR (1946) Radiological use of fast protons. Radiology 47(5):487–491

    Article  CAS  PubMed  Google Scholar 

  • Yonemoto LT, Slater JD, Rossi CJ Jr, Antoine JE, Loredo L, Archambeau JO, Schulte RW, Miller DW, Teichman SL, Slater JM (1997) Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study. Int J Radiat Oncol Biol Phys 37(1):21–29

    Article  CAS  PubMed  Google Scholar 

  • Yu JB, Makarov DV, Gross C (2011) A new formula for prostate cancer lymph node risk. Int J Radiat Oncol Biol Phys 80(1):69–75

    Article  PubMed  Google Scholar 

  • Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA (2001) High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166(3):876–881

    Article  CAS  PubMed  Google Scholar 

  • Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, Shipley WU (2005) Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294(10):1233–1239

    Article  CAS  PubMed  Google Scholar 

  • Zietman AL, Bae K, Slater JD, Shipley WU, Efstathiou JA, Coen JJ, Bush DA, Lunt M, Spiegel DY, Skowronski R et al (2010a) Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09. J Clin Oncol Off J Am Soc Clin Oncol 28(7):1106–1111

    Article  Google Scholar 

  • Zietman A, Goitein M, Tepper JE (2010b) Technology evolution: is it survival of the fittest? J Clin Oncol Off J Am Soc Clin Oncol 28(27):4275–4279

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiologische Universitätsklinik, Strahlenklinik, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany

    Gregor Habl & Jürgen Debus

Authors
  1. Gregor Habl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen Debus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregor Habl .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Krankenhaus der Barmherzigen, Schwestern Linz, Johannes Kepler University, Linz, Austria

    Hans Geinitz

  2. University of California, San Francisco Department of Radiation Oncology, San Francisco, California, USA

    Mack Roach III

  3. The Institute of Cancer Research Sutton, Sutton Surrey, United Kingdom

    Nicholas van As

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Habl, G., Debus, J. (2014). There is Evidence for the Superiority of Protons and Heavy Ions, Pro. In: Geinitz, H., Roach III, M., van As, N. (eds) Radiotherapy in Prostate Cancer. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2014_972

Download citation

  • DOI: https://doi.org/10.1007/174_2014_972

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37098-4

  • Online ISBN: 978-3-642-37099-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation